Jim Simons Immunocore Holdings PLC Transaction History
Renaissance Technologies LLC
- $70.6 Billion
- Q2 2025
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Immunocore Holdings PLC stock. As of the latest transaction made, Renaissance Technologies LLC holds 222,052 shares of IMCR stock, worth $7.55 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
222,052
Previous 90,570
145.17%
Holding current value
$7.55 Million
Previous $2.69 Million
159.29%
% of portfolio
0.01%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding IMCR
# of Institutions
146Shares Held
45.1MCall Options Held
297KPut Options Held
1.17M-
T. Rowe Price Investment Management, Inc. Baltimore, MD7.07MShares$240 Million0.14% of portfolio
-
Rtw Investments, LP New York, NY4.87MShares$166 Million2.35% of portfolio
-
Wellington Management Group LLP Boston, MA4.21MShares$143 Million0.03% of portfolio
-
Primecap Management CO Pasadena, CA3.77MShares$128 Million0.1% of portfolio
-
Bellevue Group Ag Kuesnacht, V82.44MShares$83 Million1.74% of portfolio
About Immunocore Holdings plc
- Ticker IMCR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,897,100
- Market Cap $1.49B
- Description
- Immunocore Holdings plc, a commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases. The company offers KIMMTRAK for the treatment of patients with unresectable or metastatic uveal melanoma. Its other programs for oncology comprise IMC-C103C that is in ...